Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA...

Area of Science:

• Nanomedicine
• Polymer Chemistry
• Drug Delivery Systems

Background:

• Polymeric nanoparticles offer improved drug bioavailability and targeted delivery compared to traditional methods.
• Understanding nanoparticle preparation parameters (size, drug loading, release) is crucial for formulation development.

Purpose of the Study:

• To develop and characterize formoterol polymeric nanoparticles for potential therapeutic applications.
• To optimize nanoparticle formulation for enhanced drug loading and controlled release.
• To investigate the impact of polymer and emulsion modifications on nanoparticle performance.

Main Methods:

• Polymeric nanoparticles were synthesized using solvent emulsion methods with modified poly(lactic-co-glycolic acid) (PLGA) and polyethylene glycol (PEG).
• Amine modification of PEG was employed to enhance drug loading.
• Lyophilization was performed using sucrose or trehalose as cryoprotectants.
• Physicochemical properties (morphology, crystallinity, water content) and in vitro drug release were analyzed.

Main Results:

• Maximal drug loading was achieved with amine-modified PEG-PLGA nanoparticles.
• Successful lyophilization of nanoparticles was demonstrated using cryoprotectants without compromising size distribution.
• Comprehensive physicochemical characterization confirmed nanoparticle integrity.
• In vitro release studies showed controlled drug release, with kinetics modeling successfully applied.

Conclusions:

• Amine-modified PEG-PLGA nanoparticles represent a promising platform for formoterol delivery.
• The developed nanoparticles exhibit favorable characteristics for controlled and targeted drug release.
• This study provides a foundation for further development of polymeric nanoparticles for various therapeutic applications.